{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:44:07Z","timestamp":1792165447102,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"DOI":"10.1038\/s41366-026-02232-x","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:46:27Z","timestamp":1792161987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding pathophysiology of gallstone disease: a multi-omic analysis focused on adult women with obesity"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5200-8215","authenticated-orcid":false,"given":"Jacqueline B.","family":"Hoozemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimoena S. S.","family":"Guman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylke","family":"Haal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mr\u00fcm","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-4656","authenticated-orcid":false,"given":"Abraham S.","family":"Meijnikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"B\u00e4ckhed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurits","family":"de Brauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair I. Z.","family":"Acherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-7659","authenticated-orcid":false,"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert K.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-4399","authenticated-orcid":false,"given":"Victor E. A.","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"2232_CR1","doi-asserted-by":"crossref","unstructured":"Ning Q, Liu F, Fang Y, Zhu X, Liu J, Li Z. Estimating global prevalence of gallbladder stones in general population from 2000 to 2024: systematic review and meta-analysis. Ann Med. 2025 Dec 31;57:2570795.","DOI":"10.1080\/07853890.2025.2570795"},{"key":"2232_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.0953-0673.2003.01721.x","volume":"18","author":"R Aerts","year":"2003","unstructured":"Aerts R, Penninckx F. The burden of gallstone disease in Europe. Aliment Pharmacol Ther. 2003;18:49\u201353.","journal-title":"Aliment Pharmacol Ther"},{"key":"2232_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/genes16030256","volume":"16","author":"A P\u0119czu\u0142a","year":"2025","unstructured":"P\u0119czu\u0142a A, Czaplicki A, Przyby\u0142kowski A. Genetics of gallstones. Genes. 2025;16:256.","journal-title":"Genes"},{"key":"2232_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07460-y","volume":"9","author":"E Ferkingstad","year":"2018","unstructured":"Ferkingstad E, Oddsson A, Gretarsdottir S, Benonisdottir S, Thorleifsson G, Deaton AM, et al. Genome-wide association meta-analysis yields 20 loci associated with gallstone disease. Nat Commun. 2018;9:5101.","journal-title":"Nat Commun"},{"key":"2232_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.gastro.2016.04.007","volume":"151","author":"AD Joshi","year":"2016","unstructured":"Joshi AD, Andersson C, Buch S, Stender S, Noordam R, Weng LC, et al. Four susceptibility loci for gallstone disease identified in a meta-analysis of genome-wide association studies. Gastroenterology. 2016;151:351\u2013363.e28.","journal-title":"Gastroenterology"},{"key":"2232_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1194\/jlr.S091199","volume":"60","author":"M Rudling","year":"2019","unstructured":"Rudling M, Laskar A, Straniero S. Gallbladder bile supersaturated with cholesterol in gallstone patients preferentially develops from shortage of bile acids. J Lipid Res. 2019;60:498\u2013505.","journal-title":"J Lipid Res"},{"key":"2232_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstr\u00f6m A, Felin J, J\u00e4ntti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR Antagonist. Cell Metab. 2013;17:225\u201335.","journal-title":"Cell Metab"},{"key":"2232_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01101-1","volume":"9","author":"DV Guzior","year":"2021","unstructured":"Guzior DV, Quinn RA. Review: microbial transformations of human bile acids. Microbiome. 2021;9:140.","journal-title":"Microbiome"},{"key":"2232_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/MOG.0000000000000423","volume":"34","author":"A Di Ciaula","year":"2018","unstructured":"Di Ciaula A, Wang DQH, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr Opin Gastroenterol. 2018;34:71\u201380.","journal-title":"Curr Opin Gastroenterol"},{"key":"2232_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/1758-2229.12319","volume":"7","author":"N Keren","year":"2015","unstructured":"Keren N, Konikoff FM, Paitan Y, Gabay G, Reshef L, Naftali T, et al. Interactions between the intestinal microbiota and bile acids in gallstones patients. Environ Microbiol Rep. 2015;7:874\u201380.","journal-title":"Environ Microbiol Rep"},{"key":"2232_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86247-6","volume":"11","author":"F Frost","year":"2021","unstructured":"Frost F, Kacprowski T, R\u00fchlemann M, Weiss S, Bang C, Franke A, et al. Carrying asymptomatic gallstones is not associated with changes in intestinal microbiota composition and diversity but cholecystectomy with significant dysbiosis. Sci Rep. 2021;11:6677.","journal-title":"Sci Rep"},{"key":"2232_CR12","doi-asserted-by":"crossref","unstructured":"Yang W, Wu H, Cai X, Lin C, Luo Y, Hu S, et al. Weight reduction and the risk of gallbladder and biliary disease: a systematic review and meta-analysis of randomized clinical trials. Obesity Reviews. 2024;25:e13725.","DOI":"10.1111\/obr.13725"},{"key":"2232_CR13","doi-asserted-by":"crossref","unstructured":"Wang K, Liu Z, Tang R, Sha Y, Wang Z, Chen Y, et al. Gallstones in the era of metabolic syndrome: pathophysiology, risk prediction, and management. Cureus. 2025;17:e80541.","DOI":"10.7759\/cureus.80541"},{"key":"2232_CR14","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/hep.26563","volume":"58","author":"S Stender","year":"2013","unstructured":"Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology. 2013;58:2133\u201341.","journal-title":"Hepatology"},{"key":"2232_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.gastha.2024.03.005","volume":"3","author":"VT M\u00e4nnist\u00f6","year":"2024","unstructured":"M\u00e4nnist\u00f6 VT, Kaminska D, Haal S, Asteljoki J, Luukkonen PK, K\u00e4kel\u00e4 P, et al. Protein phosphatase 1 regulatory subunit 3 beta rs4240624 genotype is associated with gallstones and with significant changes in bile lipidome. Gastro Hep Adv. 2024;3:594\u2013601.","journal-title":"Gastro Hep Adv"},{"key":"2232_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1194\/jlr.M059121","volume":"56","author":"O de Bari","year":"2015","unstructured":"de Bari O, Wang TY, Liu M, Portincasa P, Wang DQH. Estrogen induces two distinct cholesterol crystallization pathways by activating ER\u03b1 and GPR30 in female mice. J Lipid Res. 2015;56:1691\u2013700.","journal-title":"J Lipid Res"},{"key":"2232_CR17","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/hep.31212","volume":"72","author":"HH Wang","year":"2020","unstructured":"Wang HH, de Bari O, Arnatt CK, Liu M, Portincasa P, Wang DQ-H. Activation of estrogen receptor g protein\u2013coupled receptor 30 enhances cholesterol cholelithogenesis in female mice. Hepatology. 2020;72:2077\u201389.","journal-title":"Hepatology"},{"key":"2232_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31695-w","volume":"8","author":"A Baars","year":"2018","unstructured":"Baars A, Oosting A, Lohuis M, Koehorst M, El Aidy S, Hugenholtz F, et al. Sex differences in lipid metabolism are affected by presence of the gut microbiota. Sci Rep. 2018;8:13426.","journal-title":"Sci Rep"},{"key":"2232_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/joim.13157","volume":"289","author":"CC Van Olden","year":"2021","unstructured":"Van Olden CC, Van de Laar AW, Meijnikman AS, Aydin O, Van Olst N, Hoozemans JB, et al. A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study. J Intern Med. 2021;289:340\u201354.","journal-title":"J Intern Med"},{"key":"2232_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/metabo11100682","volume":"11","author":"S Haal","year":"2021","unstructured":"Haal S, Guman MSS, Acherman YIZ, Jansen JPG, van Weeghel M, van Lenthe H, et al. Gallstone formation follows a different trajectory in bariatric patients compared to nonbariatric patients. Metabolites. 2021;11:682.","journal-title":"Metabolites"},{"key":"2232_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2022.100280","volume":"63","author":"MSS Guman","year":"2022","unstructured":"Guman MSS, Hoozemans JB, Haal S, de Jonge PA, Aydin \u00d6, Lappa D, et al. Adipose tissue, bile acids, and gut microbiome species associated with gallstones after bariatric surgery. J Lipid Res. 2022;63:100280.","journal-title":"J Lipid Res"},{"key":"2232_CR22","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u201390.","journal-title":"Bioinformatics"},{"key":"2232_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:257.","journal-title":"Genome Biol"},{"key":"2232_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/biom12040550","volume":"12","author":"H Sun","year":"2022","unstructured":"Sun H, Warren J, Yip J, Ji Y, Hao S, Han W, et al. Factors influencing gallstone formation: a review of the literature. Biomolecules. 2022;12:550.","journal-title":"Biomolecules"},{"key":"2232_CR25","doi-asserted-by":"publisher","unstructured":"Nair RK, Parikh MA, Frishman WH, Peterson SJ. Sitosterolemia and early atherosclerosis: a review of genetic mechanisms and newer diagnostic methods. Cardiol Rev. 2025; https:\/\/doi.org\/10.1097\/CRD.0000000000001098. Epub ahead of print.","DOI":"10.1097\/CRD.0000000000001098"},{"key":"2232_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood.2020010029","volume":"138","author":"FK Stevenson","year":"2021","unstructured":"Stevenson FK, Forconi F, Kipps TJ. Exploring the pathways to chronic lymphocytic leukemia. Blood. 2021;138:827\u201335.","journal-title":"Blood"},{"key":"2232_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2018.07.004","volume":"276","author":"AR Tall","year":"2018","unstructured":"Tall AR. Plasma high density lipoproteins: therapeutic targeting and links to atherogenic inflammation. Atherosclerosis. 2018;276:39\u201343.","journal-title":"Atherosclerosis"},{"key":"2232_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cmet.2005.01.002","volume":"1","author":"MA Kennedy","year":"2005","unstructured":"Kennedy MA, Barrera GC, Nakamura K, Bald\u00e1n \u00c1, Tarr P, Fishbein MC, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 2005;1:121\u201331.","journal-title":"Cell Metab"},{"key":"2232_CR29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/2211-5463.13376","volume":"12","author":"H Yamamoto","year":"2022","unstructured":"Yamamoto H, Uramaru N, Kawashima A, Higuchi T. Carbonic anhydrase 3 increases during liver adipogenesis even in pre-obesity, and its inhibitors reduce liver adipose accumulation. FEBS Open Biol. 2022;12:827\u201334.","journal-title":"FEBS Open Biol"},{"key":"2232_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48525-3","volume":"13","author":"R Ohue-Kitano","year":"2023","unstructured":"Ohue-Kitano R, Masujima Y, Nishikawa S, Iwasa M, Nishitani Y, Kawakami H, et al. 3-(4-Hydroxy-3-methoxyphenyl) propionic acid contributes to improved hepatic lipid metabolism via GPR41. Sci Rep. 2023;13:21246.","journal-title":"Sci Rep"},{"key":"2232_CR31","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.3390\/ijms25137379","volume":"25","author":"Y Du","year":"2024","unstructured":"Du Y, He C, An Y, Huang Y, Zhang H, Fu W, et al. The role of short chain fatty acids in inflammation and body health. Int J Mol Sci. 2024;25:7379.","journal-title":"Int J Mol Sci"},{"key":"2232_CR32","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1128\/IAI.67.4.1614-1622.1999","volume":"67","author":"JC van Velkinburgh","year":"1999","unstructured":"van Velkinburgh JC, Gunn JS. PhoP-PhoQ-regulated loci are required for enhanced bile resistance in Salmonella spp. Infect Immun. 1999;67:1614\u201322.","journal-title":"Infect Immun"},{"key":"2232_CR33","doi-asserted-by":"crossref","unstructured":"Boyang H, Yanjun Y, Jing Z, Chenxin Y, Ying M, Shuwen H, et al. Investigating the influence of the gut microbiome on cholelithiasis: unveiling insights through sequencing and predictive modeling. J Appl Microbiol. 2024;135:lxae096.","DOI":"10.1093\/jambio\/lxae096"},{"key":"2232_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/cells9020281","volume":"9","author":"S Hohenester","year":"2020","unstructured":"Hohenester S, Kanitz V, Kremer AE, Paulusma CC, Wimmer R, Kuehn H, et al. Glycochenodeoxycholate promotes liver fibrosis in mice with hepatocellular cholestasis. Cells. 2020;9:281.","journal-title":"Cells"},{"key":"2232_CR35","doi-asserted-by":"publisher","first-page":"e0305170","DOI":"10.1371\/journal.pone.0305170","volume":"19","author":"X Han","year":"2024","unstructured":"Han X, Wang J, Wu Y, Gu H, Zhao N, Liao X, et al. Predictive value of bile acids as metabolite biomarkers for gallstone disease: a systematic review and meta-analysis. PLoS One. 2024;19:e0305170.","journal-title":"PLoS One"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02232-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02232-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02232-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:46:28Z","timestamp":1792161988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02232-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":35,"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02232-x","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M Nieuwdorp is co-founder and member of the Scientific Advisory Board of Caelus Pharmaceuticals and Advanced Microbiota Therapeutics, the Netherlands. MN is also on the board of directors of Diabeter Netherlands BV. However, none of these bear any relevance to the content of this current manuscript. None of these are directly relevant to the current paper. There are no patents, products in development or marketed products to declare. The other authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}